PT585986E - Metodo e meios para terapia dirigida a um local - Google Patents

Metodo e meios para terapia dirigida a um local Download PDF

Info

Publication number
PT585986E
PT585986E PT93202174T PT93202174T PT585986E PT 585986 E PT585986 E PT 585986E PT 93202174 T PT93202174 T PT 93202174T PT 93202174 T PT93202174 T PT 93202174T PT 585986 E PT585986 E PT 585986E
Authority
PT
Portugal
Prior art keywords
isotope
therapy
dose
isotopes
targeting moiety
Prior art date
Application number
PT93202174T
Other languages
English (en)
Portuguese (pt)
Inventor
Maurits Willem Geerlings
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PT585986E publication Critical patent/PT585986E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G4/00—Radioactive sources
    • G21G4/04—Radioactive sources other than neutron sources
    • G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
    • G21G4/08—Radioactive sources other than neutron sources characterised by constructional features specially adapted for medical application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Engineering & Computer Science (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Tents Or Canopies (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Massaging Devices (AREA)
PT93202174T 1992-07-27 1993-07-22 Metodo e meios para terapia dirigida a um local PT585986E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92202301 1992-07-27
EP93200388 1993-02-11

Publications (1)

Publication Number Publication Date
PT585986E true PT585986E (pt) 2002-03-28

Family

ID=26131590

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93202174T PT585986E (pt) 1992-07-27 1993-07-22 Metodo e meios para terapia dirigida a um local

Country Status (15)

Country Link
US (2) US5641471C1 (ko)
EP (1) EP0585986B1 (ko)
JP (1) JP3959431B2 (ko)
KR (1) KR100304155B1 (ko)
AT (1) ATE206622T1 (ko)
AU (1) AU676162B2 (ko)
CA (1) CA2100709C (ko)
DE (1) DE69330899T2 (ko)
DK (1) DK0585986T3 (ko)
ES (1) ES2165361T3 (ko)
FI (1) FI118676B (ko)
MX (1) MX9304499A (ko)
NO (1) NO312009B1 (ko)
NZ (1) NZ248235A (ko)
PT (1) PT585986E (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403771B1 (en) 1991-02-19 2002-06-11 Actinium Pharmaceuticals, Limited Method and means for site directed therapy
CA2100709C (en) * 1992-07-27 2004-03-16 Maurits W. Geerlings Method and means for site directed therapy
DE69623482T2 (de) * 1996-11-15 2003-01-30 European Atomic Energy Community (Euratom), Luxemburg/Luxembourg Ex-Corpore Verfahren zur Behändlung von Blut-Zellen
US5749042A (en) * 1997-01-28 1998-05-05 Battelle Memorial Institute Bismuth generator method
US5854968A (en) * 1997-06-09 1998-12-29 Arch Development Corporation Process and apparatus for the production of BI-213 cations
US6603127B1 (en) * 1998-03-30 2003-08-05 Sloan-Kettering Institute For Cancer Research Bismuth-213 generator and uses thereof
US7736651B1 (en) 2000-11-24 2010-06-15 Sloan-Kettering Institute For Cancer Research Alpha emitting constructs and uses thereof
WO1999061097A2 (en) * 1998-05-26 1999-12-02 Sloan-Kettering Institute For Cancer Research Alpha emitting constructs and uses thereof
ES2203856T3 (es) * 1998-06-22 2004-04-16 European Community Metodo y aparato para la preparacion de bi-213 para uso terapeutico humano.
JP2004510683A (ja) * 1999-06-07 2004-04-08 センター・フォー・モレキュラー・メディシン・アンド・イムノロジー 放射免疫療法において断片に付着されるα線エミッタまたはβ線エミッタ
US6852296B2 (en) * 2001-06-22 2005-02-08 Pg Research Foundation Production of ultrapure bismuth-213 for use in therapeutic nuclear medicine
US7087206B2 (en) * 2002-04-12 2006-08-08 Pg Research Foundation Multicolumn selectivity inversion generator for production of high purity actinium for use in therapeutic nuclear medicine
WO2004001767A1 (en) * 2002-06-21 2003-12-31 Lynntech, Inc. Ion exchange materials for use in a bi-213 generator
EP1479399A1 (en) * 2003-05-22 2004-11-24 European Atomic Energy Community (Euratom) Method of loading a radioelement generator with mother radionuclide
US20050105666A1 (en) * 2003-09-15 2005-05-19 Saed Mirzadeh Production of thorium-229
IN2012DN00551A (ko) 2009-07-22 2015-06-12 Actinium Pharmaceuticals Inc
JP2018518476A (ja) 2015-06-05 2018-07-12 パナシア ファーマシューティカルズ， インコーポレイテッド Ｈａａｈに対する抗体を使用するがんの放射線イメージングおよび放射線療法
EP3409297A1 (en) 2017-05-30 2018-12-05 AlfaRim Medial Holding B.V. The optimal 225actinium--213bismuth generator for alpha-particle radioimmunotherapy
US20200230266A1 (en) 2017-09-20 2020-07-23 Alfarim Medical Holding B.V. The optimal 225actinium--213bismuth generator for alpha-particle radioimmunotherapy

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001387A (en) * 1973-07-30 1977-01-04 Medi-Physics, Inc. Process for preparing radiopharmaceuticals
US4305922A (en) * 1978-10-04 1981-12-15 University Patents, Inc. Labeling proteins with 99m-Tc by ligand exchange
US4296785A (en) * 1979-07-09 1981-10-27 Mallinckrodt, Inc. System for generating and containerizing radioisotopes
CA1225930A (en) * 1982-06-07 1987-08-25 Otto A. Gansow Metal chelate conjugated monoclonal antibodies
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
US4828991A (en) * 1984-01-31 1989-05-09 Akzo N.V. Tumor specific monoclonal antibodies
US4663129A (en) * 1985-01-30 1987-05-05 The United States Of America As Represented By The United States Department Of Energy Isotopic generator for bismuth-212 and lead-212 from radium
IL87405A0 (en) * 1987-08-12 1989-01-31 Immunomedics Inc Radiolabeled agents and methods and kits for the production thereof
US4833329A (en) * 1987-11-20 1989-05-23 Mallinckrodt, Inc. System for generating and containerizing radioisotopes
US4871352A (en) * 1987-12-07 1989-10-03 Controlled Release Technologies, Inc. Self-regulated therapeutic agent delivery system and method
US4923985A (en) * 1988-05-25 1990-05-08 The United States Of America As Represented By The Department Of Health & Human Services Process for synthesizing macrocyclic chelates
AU630362B2 (en) * 1988-05-25 1992-10-29 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Macrocyclic chelates & methods of use thereof
DK0429624T3 (da) * 1989-06-19 1994-05-30 Akzo Nobel Nv Radioimmunterapi under anvendelse af alfa-partikelemission
EP0484460B1 (en) * 1989-07-12 1996-01-17 Mallinckrodt Medical, Inc. Method for preparing radiodiagnostic gaseous radionuclide and apparatus
LU87684A1 (de) * 1990-02-23 1991-10-08 Euratom Verfahren zur erzeugung von aktinium-225 und wismut-213
US5038046A (en) * 1990-07-10 1991-08-06 Biotechnetics Method and generator for producing radioactive lead-212
CA2100709C (en) * 1992-07-27 2004-03-16 Maurits W. Geerlings Method and means for site directed therapy

Also Published As

Publication number Publication date
MX9304499A (es) 1994-04-29
KR100304155B1 (ko) 2001-11-22
EP0585986B1 (en) 2001-10-10
US6127527A (en) 2000-10-03
FI118676B (fi) 2008-02-15
US5641471C1 (en) 2001-05-15
NO932687D0 (no) 1993-07-26
NO932687L (no) 1994-01-28
JPH06157350A (ja) 1994-06-03
ES2165361T3 (es) 2002-03-16
NO312009B1 (no) 2002-03-04
ATE206622T1 (de) 2001-10-15
AU676162B2 (en) 1997-03-06
US5641471A (en) 1997-06-24
CA2100709A1 (en) 1994-01-28
CA2100709C (en) 2004-03-16
FI933350A (fi) 1994-01-28
AU4215493A (en) 1994-02-03
DE69330899T2 (de) 2002-04-25
NZ248235A (en) 1995-04-27
KR940005295A (ko) 1994-03-21
DE69330899D1 (de) 2001-11-15
EP0585986A1 (en) 1994-03-09
JP3959431B2 (ja) 2007-08-15
DK0585986T3 (da) 2002-01-14
FI933350A0 (fi) 1993-07-26

Similar Documents

Publication Publication Date Title
PT585986E (pt) Metodo e meios para terapia dirigida a um local
US20140235924A1 (en) Method of radiotherapy
ES2250419T3 (es) Radioterapia.
Wilbur et al. Preparation and evaluation of para-[211At] astatobenzoyl labeled anti-renal cell carcinoma antibody A6H F (ab′) 2. In vivo distribution comparison with para-[125I] iodobenzoyl labeled A6H F (ab′) 2
JP5468597B2 (ja) 軟組織疾患の放射線治療におけるトリウム−２２７を用いた医薬組成物、複合体及びその調製方法、並びにキット
Chakraborty et al. Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small joints
US20080279772A1 (en) Methods for detecting pathological sites
US20060228297A1 (en) Thorium-227 for use in radiotherapy of soft tissue disease
Larsen et al. α-Particle radiotherapy with 211At-labeled monodisperse polymer particles, 211At-labeled IgG proteins, and free 211At in a murine intraperitoneal tumor model
Larsen et al. Intratumour injection of immunoglobulins labelled with the α-particle emitter 211At: analyses of tumour retention, microdistribution and growth delay
Ehrhardt et al. Radioisotope radiotherapy research and achievements at the University of Missouri Research Reactor
Vagahasiya et al. RADIOPHARMACEUTICAL IN NUCLEAR PHARMACY & MEDICINE AND THEIR THERAPEUTICS APPLICATION IN HEALTH CARE SYSTEM
Ünak Recent advances in medical radionuclide production and future perspective of compact medical cyclotrons
Beyer et al. Use of radioactive ion beams for bio-medical research
Weinreich et al. I-124 and its applications in nuclear medicine and biology
Virawat et al. Optimization of the production, quality control of samarium-153, 153 Sm-EDTMP and biodistribution of 153 Sm-EDTMP in animals for metastatic bone cancer pain palliation
Schlesinger et al. Radiation dosimetry of the Os-191/Ir-191m generator eluate
Saichi et al. 153-EDTMP for palliation of pain from osseous metastases: Preparation and biodistribution studies
Yongxian et al. Yu Junfeng, Yin Duanzhi, Min Xiaofeng, 2 Guo Zili, Zhang Jiong